Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. [electronic resource]
Producer: 20091207Description: 438-446 p. digitalISSN:- 1437-7799
- Animals
- Antibiotics, Antineoplastic -- toxicity
- Antidiuretic Hormone Receptor Antagonists
- Benzazepines -- therapeutic use
- Desmin -- metabolism
- Humans
- Intracellular Signaling Peptides and Proteins -- metabolism
- Kidney Glomerulus -- cytology
- Male
- Membrane Proteins -- metabolism
- Nephrosis -- chemically induced
- Organ Size
- Podocytes -- drug effects
- Puromycin Aminonucleoside -- toxicity
- Rats
- Rats, Sprague-Dawley
- Tolvaptan
- WT1 Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.